ÂÜÀòÂÒÂ×

Dr. Judith van Walsum was elected to the Board of Dätwyler Holding Inc. as representative of the public shareholders at the 2022 Annual General Meeting. She has been Chief Financial Officer (CFO) and Head of IT at Roche Diabetes Care, a globally operating business divison of Roche Group since 2018. From 2004 to 2018, the Dutchwoman has held diverse global managerial functions for Roche Group, among which Head of HR Operations and Head of Finance and Intercompany Supply Chain for Roche Diagnostics. From 1999 to 2004, she was Senior Manager in Financial Strategy, Process and Transformation for KPMG in Frankfurt. Dr. Judith van Walsum has undergone studies at several universities and has a Ph.D in international political economy at the London School of Economics.